Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effect of NMES on Spasticity

NCT: NCT07617311 · NOT_YET_RECRUITING

NCT IDNCT07617311
StatusNOT_YET_RECRUITING
Start Date2026-06-15
Completion2028-03-16
SponsorIzmir Katip Celebi University (OTHER)
First posted
Last updated

Brief Summary

The goal of this clinical trial is to learn if neuromuscular electrical stimulation (NMES) works to treat spasticity in adult patients with spasticity related to stroke. The main question it aims to answer is: • Does NMES reduces the severity of spasticity? Researchers will compare NMES treatment to baseline and non-stimulation periods to see if NMES works to treat spasticity. Participants will: • first undergo an initial assessment at 10-minute intervals for one hour, followed by 20 minutes of NMES exposure, and subsequent post-treatment assessments at 10-minute intervals for two hours. This daily procedure will be repeated over four days for one patient, and performed only once for the remaining three patients.

Frequently Asked Questions

What is Effect of NMES on Spasticity?

Effect of NMES on Spasticity is a clinical trial registered under NCT07617311. Current status: NOT_YET_RECRUITING.

What is the status of NCT07617311?

The current status of NCT07617311 (Effect of NMES on Spasticity) is: NOT_YET_RECRUITING.

When did Effect of NMES on Spasticity start?

Effect of NMES on Spasticity started on 2026-06-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.